American private equity company KKR&Co. will acquire a majority stake in Healthcare Global Enterprises Ltd. for approximately 3,350 crore.
Promoter Entity CVC Asia on Sunday announced that it will be decisive with KKR-Affiliate Hector Asia Holdings II PTE and KIA EBT II Scheme 1 for the sale of up to 54% of its diluted voting stock capital, according to an exchange application I have signed a contract.
CVC currently owns a 60.35% stake in HCG via ARM Aceso Co.
The first tranches of the transaction include the acquisition of 51% stake. The second tranches of 3% will only be acquired if the KKR additional 26% shares of public offer is not passed.
The open offer is totaling Rs 1,870 crore and consists of a maximum of 3.7 crore stocks of Rs 504.41.
Once the transaction is closed, KKR is expected to hold between 54-77% of the shares, Filing said. The transaction is expected to close by the third quarter of 2025 and is subject to customary closure conditions and regulatory approval.
HCG founder BS Ajaikumar will take on the role of non-executive chairman and will focus on driving clinical, academic and research and development. He owns a 10.4% stake.
Cancer Care Provider operates 25 medical centres in 19 Indian cities, with capacity of 2,500 beds, almost 100 operating theatres and 40 linear accelerator machines.
